Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines

Genome Medicine

Volumn 2, Issue 4, 2010, Pages

  Sarachana, Tewarit ^a   Zhou, Rulun ^b   Chen, Guang ^b   Manji, Husseini K ^b   Hu, Valerie W ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA;

ARTICLE; AUTISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; GASTROINTESTINAL DISEASE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; GENE SILENCING; GENE TARGETING; HUMAN; LYMPHOBLASTOID CELL LINE; MALE; MEMORY; MICROARRAY ANALYSIS; MONOZYGOTIC TWINS; NERVE CELL PLASTICITY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TWIN DISCORDANCE;

EID: 78751689926     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm144     Document Type: Article

References (146)

1. Volkmar F, Chawarska K, Klin A. Autism in infancy and early childhood. Annu Rev Psychol 2005, 56:315-336. 10.1146/annurev.psych.56.091103.070159, 15709938.
2. Barton M, Volkmar F. How commonly are known medical conditions associated with autism?. J Autism Dev Disord 1998, 28:273-278. 10.1023/A:1026052417561, 9711483.
3. Rutter M, Bailey A, Bolton P, Le Couteur A. Autism and known medical conditions: myth and substance. J Child Psychol Psychiatry 1994, 35:311-322. 10.1111/j.1469-7610.1994.tb01164.x, 8188801.
4. Volkmar FR, Lord C, Bailey A, Schultz RT, Klin A. Autism and pervasive developmental disorders. J Child Psychol Psychiatry 2004, 45:135-170. 10.1046/j.0021-9630.2003.00317.x, 14959806.
5. International Molecular Genetic Study of Autism Consortium (IMGSAC) A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001, 69:570-581. 10.1086/323264, 1235486, 11481586, International Molecular Genetic Study of Autism Consortium (IMGSAC).
6. Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Ylisaukko-Oja T, Sinsheimer JS, Peltonen L, Jarvela I. A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 2002, 71:777-790. 10.1086/342720, 378535, 12192642.
7. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, Grunn A, Juo SH, Terwilliger JD, Liu J, Cantor RM, Geschwind DH, Gilliam TC. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003, 73:886-897. 10.1086/378778, 1180610, 13680528.
8. Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Van Maldergem L, Penet C, Feingold J, Brice A, Leboyer M. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 1999, 8:805-812. 10.1093/hmg/8.5.805, 10196369.
9. International Molecular Genetic Study of Autism Consortium (IMGSAC) Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum Mol Genet 2001, 10:973-982. 10.1093/hmg/10.9.973, 11392322, International Molecular Genetic Study of Autism Consortium (IMGSAC).
10. McCauley JL, Li C, Jiang L, Olson LM, Crockett G, Gainer K, Folstein SE, Haines JL, Sutcliffe JS. Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Med Genet 2005, 6:1. 10.1186/1471-2350-6-1, 546213, 15647115.
11. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ, . Autism Consortium Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675. 10.1056/NEJMoa075974, 18184952, Autism Consortium.
12. Lise MF, El-Husseini A. The neuroligin and neurexin families: from structure to function at the synapse. Cell Mol Life Sci 2006, 63:1833-1849. 10.1007/s00018-006-6061-3, 16794786.
13. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T, . Paris Autism Research International Sibpair Study Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29. 10.1038/ng1136, 1925054, 12669065, Paris Autism Research International Sibpair Study.
14. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007, 39:25-27. 10.1038/ng1933, 2082049, 17173049.
15. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, Lally E, Weiss LA, Najm J, Kutsche K, Descartes M, Holt L, Braddock S, Troxell R, Kaplan L, Volkmar F, Klin A, Tsatsanis K, Harris DJ, Noens I, Pauls DL, Daly MJ, MacDonald ME, Morton CC, Quade BJ, Gusella JF. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008, 82:199-207. 10.1016/j.ajhg.2007.09.011, 2253961, 18179900.
16. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, Rea A, Guy M, Lin S, Cook EH, Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008, 82:160-164. 10.1016/j.ajhg.2007.09.015, 2253968, 18179894.
17. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM, Sebat J, Wigler M, Martin CL, Ledbetter DH, Nelson SF, Cantor RM, Geschwind DH. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008, 82:150-159. 10.1016/j.ajhg.2007.09.005, 2253955, 18179893.
18. Bakkaloglu B, O'Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM, Chawarska K, Klin A, Ercan-Sencicek AG, Stillman AA, Tanriover G, Abrahams BS, Duvall JA, Robbins EM, Geschwind DH, Biederer T, Gunel M, Lifton RP, State MW. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008, 82:165-173. 10.1016/j.ajhg.2007.09.017, 2253974, 18179895.
19. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol 2009, 19:231-234. 10.1016/j.conb.2009.06.003, 19545994.
20. Geschwind DH. Autism: the ups and downs of neuroligin. Biol Psychiatry 2009, 66:904-905. 10.1016/j.biopsych.2009.09.022, 19874940.
21. Hu VW, Frank BC, Heine S, Lee NH, Quackenbush J. Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics 2006, 7:118. 10.1186/1471-2164-7-118, 1525191, 16709250.
22. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67-81. 10.1002/ana.20315, 15546155.
23. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355. 10.1038/nature02871, 15372042.
24. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
25. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell 2004, 16:861-865. 10.1016/j.molcel.2004.12.002, 15610730.
26. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005, 6:376-385. 10.1038/nrm1644, 15852042.
27. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524. 10.1126/science.1111444, 16141061.
28. Rogaev EI. Small RNAs in human brain development and disorders. Biochemistry 2005, 70:1404-1407.
29. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224. 10.1126/science.1140481, 2782470, 17761882.
30. Mehler MF, Mattick JS. Non-coding RNAs in the nervous system. J Physiol 2006, 575:333-341. 10.1113/jphysiol.2006.113191, 1819441, 16809366.
31. Kapsimali M, Kloosterman WP, de Bruijn E, Rosa F, Plasterk RH, Wilson SW. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol 2007, 8:R173. 10.1186/gb-2007-8-8-r173, 2375003, 17711588.
32. Caudy AA, Myers M, Hannon GJ, Hammond SM. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 2002, 16:2491-2496. 10.1101/gad.1025202, 187452, 12368260.
33. Ishizuka A, Siomi MC, Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 2002, 16:2497-2508. 10.1101/gad.1022002, 187455, 12368261.
34. Jin P, Alisch RS, Warren ST. RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 2004, 6:1048-1053. 10.1038/ncb1104-1048, 15516998.
35. Li Y, Lin L, Jin P. The microRNA pathway and fragile X mental retardation protein. Biochim Biophys Acta 2008, 1779:702-705. 2607293, 18687414.
36. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry 2007, 72:578-582.
37. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, Rappsilber J, Mann M, Dreyfuss G. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 2002, 16:720-728. 10.1101/gad.974702, 155365, 11914277.
38. Talebizadeh Z, Butler MG, Theodoro MF. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res 2008, 1:240-250. 10.1002/aur.33, 2768334, 19360674.
39. Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K, Kosik KS. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008, 9:153-161. 10.1007/s10048-008-0133-5, 18563458.
40. Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, Scully MA, Soldin SJ, Luu T, Lee NH. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One 2009, 4:e5775. 10.1371/journal.pone.0005775, 2685981, 19492049.
41. Chen Y, Kamat V, Dougherty ER, Bittner ML, Meltzer PS, Trent JM. Ratio statistics of gene expression levels and applications to microarray data analysis. Bioinformatics 2002, 18:1207-1215. 10.1093/bioinformatics/18.9.1207, 12217912.
42. Dudoit S, Gentleman RC, Quackenbush J. Open source software for the analysis of microarray data. BioTechniques 2003, (Suppl):45-51.
43. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. BioTechniques 2003, 34:374-378.
44. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002, 32(Suppl):496-501. 10.1038/ng1032, 12454644.
45. Pavlidis P, Noble WS. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol 2001, 2:RESEARCH0042. 10.1186/gb-2001-2-10-research0042, 57797, 11597334.
46. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-144. 10.1093/nar/gkj112, 1347474, 16381832.
47. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517. 10.1261/rna.5248604, 1370637, 15383676.
48. R Development Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria 2009, R Development Core Team.
49. Jakymiw A, Pauley KM, Li S, Ikeda K, Lian S, Eystathioy T, Satoh M, Fritzler MJ, Chan EK. The role of GW/P-bodies in RNA processing and silencing. J Cell Sci 2007, 120:1317-1323. 10.1242/jcs.03429, 17401112.
50. Komoto J, Usui S, Otsuki S, Terao A. Infantile autism and Duchenne muscular dystrophy. J Autism Dev Disord 1984, 14:191-195. 10.1007/BF02409661, 6746506.
51. Zwaigenbaum L, Bryson S, Rogers T, Roberts W, Brian J, Szatmari P. Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci 2005, 23:143-152. 10.1016/j.ijdevneu.2004.05.001, 15749241.
52. Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999, 135:559-563. 10.1016/S0022-3476(99)70052-1, 10547242.
53. Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002, 4:251-258. 10.1007/s11894-002-0071-6, 12010627.
54. White JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 2003, 228:639-649.
55. Jyonouchi H, Geng L, Ruby A, Reddy C, Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr 2005, 146:605-610. 10.1016/j.jpeds.2005.01.027, 15870662.
56. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005, 51:77-85. 10.1159/000084164, 15741748.
57. Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ. Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord 2005, 35:713-727. 10.1007/s10803-005-0019-4, 16267642.
58. Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 2006, 27(Suppl 2):S128-136. 10.1097/00004703-200604002-00011, 16685179.
59. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004, 5:R13. 10.1186/gb-2004-5-3-r13, 395763, 15003116.
60. Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007, 204:1553-1558. 10.1084/jem.20070823, 2118654, 17606634.
61. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166. 10.1186/1471-2164-8-166, 1904203, 17565689.
62. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003, 9:1274-1281. 10.1261/rna.5980303, 1370491, 13130141.
63. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004, 2:e363. 10.1371/journal.pbio.0020363, 521178, 15502875.
64. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105. 10.1101/gr.082701.108, 2612969, 18955434.
65. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
66. Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, Anand S, Cutillo L, Ballabio A, Banfi S. MicroRNA target prediction by expression analysis of host genes. Genome Res 2009, 19:481-490. 10.1101/gr.084129.108, 2661810, 19088304.
67. Saccomani L, Veneselli E, Di Stefano S, Celle ME, De Negri M. Early autism and congenital muscular dystrophy: a clinical case. Pediatr Med Chir 1992, 14:231-233.
68. Duffield GE, Watson NP, Mantani A, Peirson SN, Robles-Murguia M, Loros JJ, Israel MA, Dunlap JC. A role for Id2 in regulating photic entrainment of the mammalian circadian system. Curr Biol 2009, 19:297-304. 10.1016/j.cub.2008.12.052, 2648875, 19217292.
69. Seeburg DP, Pak D, Sheng M. Polo-like kinases in the nervous system. Oncogene 2005, 24:292-298. 10.1038/sj.onc.1208277, 15640845.
70. Seeburg DP, Feliu-Mojer M, Gaiottino J, Pak DT, Sheng M. Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron 2008, 58:571-583. 10.1016/j.neuron.2008.03.021, 2488274, 18498738.
71. Seeburg DP, Sheng M. Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity. J Neurosci 2008, 28:6583-6591. 10.1523/JNEUROSCI.1853-08.2008, 18579731.
72. Wimpory D, Nicholas B, Nash S. Social timing, clock genes and autism: a new hypothesis. J Intellect Disabil Res 2002, 46:352-358. 10.1046/j.1365-2788.2002.00423.x, 12000587.
73. Nicholas B, Rudrasingham V, Nash S, Kirov G, Owen MJ, Wimpory DC. Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis. Mol Psychiatry 2007, 12:581-592. 10.1038/sj.mp.4001953, 17264841.
74. Zhang J, Fang Z, Jud C, Vansteensel MJ, Kaasik K, Lee CC, Albrecht U, Tamanini F, Meijer JH, Oostra BA, Nelson DL. Fragile X-related proteins regulate mammalian circadian behavioral rhythms. Am J Hum Genet 2008, 83:43-52. 10.1016/j.ajhg.2008.06.003, 2443847, 18589395.
75. Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb Symp Quant Biol 2007, 72:645-654. 10.1101/sqb.2007.72.020, 18419324.
76. Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsater H, Rastam M, Stahlberg O, Gillberg IC, Delorme R, Chabane N, Mouren-Simeoni MC, Fauchereau F, Durand CM, Chevalier F, Drouot X, Collet C, Launay JM, Leboyer M, Gillberg C, Bourgeron T. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008, 13:90-98. 10.1038/sj.mp.4002016, 2199264, 17505466.
77. Hu VW, Sarachana T, Kim KS, Nguyen A, Kulkarni S, Steinberg ME, Luu T, Lai Y, Lee NH. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res 2009, 2:78-97. 10.1002/aur.73, 2737477, 19418574.
78. Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness?. Trends Neurosci 1999, 22:273-280. 10.1016/S0166-2236(98)01361-7, 10354606.
79. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 2001, 158:1058-1066. 10.1176/appi.ajp.158.7.1058, 11431227.
80. Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA 2007, 104:13501-13506. 10.1073/pnas.0704391104, 1948920, 17675408.
81. Hussman JP. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 2001, 31:247-248. 10.1023/A:1010715619091, 11450824.
82. Kocerha J, Faghihi MA, Lopez-Toledano MA, Huang J, Ramsey AJ, Caron MG, Sales N, Willoughby D, Elmen J, Hansen HF, Orum H, Kauppinen S, Kenny PJ, Wahlestedt C. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci USA 2009, 106:3507-3512. 10.1073/pnas.0805854106, 2651305, 19196972.
83. Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. J Neural Transm 1998, 105:525-535. 10.1007/s007020050076, 9720980.
84. Moy SS, Nadler JJ. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 2008, 13:4-26. 10.1038/sj.mp.4002082, 17848915.
85. Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 2008, 188:178-194. 10.1016/j.bbr.2007.10.029, 2349090, 18068825.
86. Lehohla M, Kellaway L, Russell VA. NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder. Metab Brain Dis 2004, 19:35-42. 10.1023/B:MEBR.0000027415.75432.ad, 15214504.
87. Adams J, Crosbie J, Wigg K, Ickowicz A, Pathare T, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL, Barr CL. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry 2004, 9:494-499. 10.1038/sj.mp.4001455, 14699423.
88. Beneyto M, Meador-Woodruff JH. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008, 33:2175-2186. 10.1038/sj.npp.1301604, 18033238.
89. Kauselmann G, Weiler M, Wulff P, Jessberger S, Konietzko U, Scafidi J, Staubli U, Bereiter-Hahn J, Strebhardt K, Kuhl D. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J 1999, 18:5528-5539. 10.1093/emboj/18.20.5528, 1171621, 10523297.
90. Weerdt BC, Medema RH. Polo-like kinases: a team in control of the division. Cell Cycle 2006, 5:853-864.
91. Pak DT, Sheng M. Targeted protein degradation and synapse remodeling by an inducible protein kinase. Science 2003, 302:1368-1373. 10.1126/science.1082475, 14576440.
92. Sheng M, Hoogenraad CC. The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 2007, 76:823-847. 10.1146/annurev.biochem.76.060805.160029, 17243894.
93. Lampe AK, Bushby KM. Collagen VI related muscle disorders. J Med Genet 2005, 42:673-685. 10.1136/jmg.2002.002311, 1736127, 16141002.
94. Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, Marie SK, Chu ML, Swoboda K, Muntoni F, Bonnemann CG, Flanigan KM, Bushby KM, Weiss RB. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet 2005, 42:108-120. 10.1136/jmg.2004.023754, 1736000, 15689448.
95. Jobsis GJ, Keizers H, Vreijling JP, de Visser M, Speer MC, Wolterman RA, Baas F, Bolhuis PA. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat Genet 1996, 14:113-115. 10.1038/ng0996-113, 8782832.
96. Martoni E, Urciuolo A, Sabatelli P, Fabris M, Bovolenta M, Neri M, Grumati P, D'Amico A, Pane M, Mercuri E, Bertini E, Merlini L, Bonaldo P, Ferlini A, Gualandi F. Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy. Hum Mutat 2009, 30:E662-672. 10.1002/humu.21022, 19309692.
97. Ishikawa H, Sugie K, Murayama K, Awaya A, Suzuki Y, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004, 62:620-623.
98. Baker NL, Morgelin M, Peat R, Goemans N, North KN, Bateman JF, Lamande SR. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet 2005, 14:279-293. 10.1093/hmg/ddi025, 15563506.
99. Zwaigenbaum L, Tarnopolsky M. Two children with muscular dystrophies ascertained due to referral for diagnosis of autism. J Autism Dev Disord 2003, 33:193-199. 10.1023/A:1022947728569, 12757359.
100. Ming X, Brimacombe M, Wagner GC. Prevalence of motor impairment in autism spectrum disorders. Brain Dev 2007, 29:565-570. 10.1016/j.braindev.2007.03.002, 17467940.
101. Heuer JG, Li K, Kaufman TC. The Drosophila homeotic target gene centrosomin (cnn) encodes a novel centrosomal protein with leucine zippers and maps to a genomic region required for midgut morphogenesis. Development 1995, 121:3861-3876.
102. Verde I, Pahlke G, Salanova M, Zhang G, Wang S, Coletti D, Onuffer J, Jin SL, Conti M. Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J Biol Chem 2001, 276:11189-11198. 10.1074/jbc.M006546200, 11134006.
103. Kesavapany S, Li BS, Amin N, Zheng YL, Grant P, Pant HC. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 2004, 1697:143-153.
104. Mochida GH, Walsh CA. Molecular genetics of human microcephaly. Curr Opin Neurol 2001, 14:151-156. 10.1097/00019052-200104000-00003, 11262728.
105. Schumann CM, Barnes CC, Lord C, Courchesne E. Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol Psychiatry 2009, 66:942-949. 10.1016/j.biopsych.2009.07.007, 19726029.
106. Redcay E, Courchesne E. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 2005, 58:1-9. 10.1016/j.biopsych.2005.03.026, 15935993.
107. Courchesne E, Pierce K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Dev Neurosci 2005, 23:153-170. 10.1016/j.ijdevneu.2005.01.003, 15749242.
108. Carper RA, Courchesne E. Localized enlargement of the frontal cortex in early autism. Biol Psychiatry 2005, 57:126-133. 10.1016/j.biopsych.2004.11.005, 15652870.
109. Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H, Folstein SE. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997, 36:282-290. 10.1097/00004583-199702000-00019, 9031582.
110. Davis LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J, Wassink TH. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1145-1151. 10.1002/ajmg.b.30738, 2752707, 18361446.
111. Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A, Gilmore J, Piven J. Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry 2005, 62:1366-1376. 10.1001/archpsyc.62.12.1366, 16330725.
112. Hazlett HC, Poe MD, Gerig G, Smith RG, Piven J. Cortical gray and white brain tissue volume in adolescents and adults with autism. Biol Psychiatry 2006, 59:1-6. 10.1016/j.biopsych.2005.06.015, 16139816.
113. Wassink TH, Hazlett HC, Epping EA, Arndt S, Dager SR, Schellenberg GD, Dawson G, Piven J. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 2007, 64:709-717. 10.1001/archpsyc.64.6.709, 17548752.
114. Freitag CM, Luders E, Hulst HE, Narr KL, Thompson PM, Toga AW, Krick C, Konrad C. Total brain volume and corpus callosum size in medication-naive adolescents and young adults with autism spectrum disorder. Biol Psychiatry 2009, 66:316-319. 10.1016/j.biopsych.2009.03.011, 19409535.
115. Fombonne E, Roge B, Claverie J, Courty S, Fremolle J. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999, 29:113-119. 10.1023/A:1023036509476, 10382131.
116. Piven J, Arndt S, Bailey J, Havercamp S, Andreasen NC, Palmer P. An MRI study of brain size in autism. Am J Psychiatry 1995, 152:1145-1149.
117. Piven J, Arndt S, Bailey J, Andreasen N. Regional brain enlargement in autism: a magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 1996, 35:530-536.
118. Woodhouse W, Bailey A, Rutter M, Bolton P, Baird G, Le Couteur A. Head circumference in autism and other pervasive developmental disorders. J Child Psychol Psychiatry 1996, 37:665-671. 10.1111/j.1469-7610.1996.tb01458.x, 8894947.
119. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998, 57:645-652. 10.1097/00005072-199807000-00001, 9690668.
120. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA. A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3:e3652. 10.1371/journal.pone.0003652, 2575400, 18987751.
121. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007, 91:209-217. 10.1016/j.ymgme.2007.03.011, 1978064, 17521938.
122. Kotzbauer PT, Truax AC, Trojanowski JQ, Lee VM. Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. J Neurosci 2005, 25:689-698. 10.1523/JNEUROSCI.4265-04.2005, 15659606.
123. Zhang YM, Rock CO, Jackowski S. Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration. J Biol Chem 2006, 281:107-114. 10.1074/jbc.M508825200, 16272150.
124. Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 2001, 65:1-7. 10.1054/plef.2001.0281, 11487301.
125. Johnson KP, Malow BA. Sleep in children with autism spectrum disorders. Curr Treat Options Neurol 2008, 10:350-359. 10.1007/s11940-008-0038-5, 18782508.
126. Malow BA. Sleep disorders, epilepsy, and autism. Ment Retard Dev Disabil Res Rev 2004, 10:122-125. 10.1002/mrdd.20023, 15362168.
127. Hu VW, Steinberg ME. Novel clustering of items from the Autism Diagnostic Interview-Revised to define phenotypes within autism spectrum disorders. Autism Res 2009, 2:67-77. 10.1002/aur.72, 2737479, 19455643.
128. Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 1972, 42:201-206. 10.1016/0006-8993(72)90054-6, 5047187.
129. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990, 247:975-978. 10.1126/science.2305266, 2305266.
130. Cheng HY, Obrietan K. Revealing a role of microRNAs in the regulation of the biological clock. Cell Cycle 2007, 6:3034-3035.
131. Cheng HY, Papp JW, Varlamova O, Dziema H, Russell B, Curfman JP, Nakazawa T, Shimizu K, Okamura H, Impey S, Obrietan K. microRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54:813-829. 10.1016/j.neuron.2007.05.017, 2590749, 17553428.
132. Peddada S, Yasui DH, LaSalle JM. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet 2006, 15:2003-2014. 10.1093/hmg/ddl124, 1931415, 16682435.
133. Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, Cremer L, Hatchwell E. Autism and environmental genomics. Neurotoxicology 2006, 27:671-684. 10.1016/j.neuro.2006.03.017, 16644012.
134. Levy SE, Souders MC, Ittenbach RF, Giarelli E, Mulberg AE, Pinto-Martin JA. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry 2007, 61:492-497. 10.1016/j.biopsych.2006.07.013, 17207470.
135. Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007, 51:597-604. 10.1016/j.yhbeh.2007.02.001, 17462645.
136. Knickmeyer RC, Baron-Cohen S. Fetal testosterone and sex differences in typical social development and in autism. J Child Neurol 2006, 21:825-845. 10.1177/08830738060210101601, 17005117.
137. Zamani MR, Desmond NL, Levy WB. Estradiol modulates long-term synaptic depression in female rat hippocampus. J Neurophysiol 2000, 84:1800-1808.
138. MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C. Androgen modulation of hippocampal synaptic plasticity. Neuroscience 2006, 138:957-965. 10.1016/j.neuroscience.2005.12.054, 16488544.
139. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. Autism profiles of males with fragile X syndrome. Am J Ment Retard 2008, 113:427-438. 10.1352/2008.113:427-438, 2629645, 19127654.
140. Talebizadeh Z, Lam DY, Theodoro MF, Bittel DC, Lushington GH, Butler MG. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 2006, 43:e21. 10.1136/jmg.2005.036897, 2564526, 16648374.
141. Baron CA, Liu SY, Hicks C, Gregg JP. Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J Autism Dev Disord 2006, 36:973-982. 10.1007/s10803-006-0134-x, 16845580.
142. Schule B, Li HH, Fisch-Kohl C, Purmann C, Francke U. DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency. Am J Hum Genet 2007, 81:492-506. 10.1086/520063, 1950824, 17701895.
143. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol 2005, 3:e85. 10.1371/journal.pbio.0030085, 1043860,1043860, 15723116.
144. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
145. Lai EC. Predicting and validating microRNA targets. Genome Biol 2004, 5:115. 10.1186/gb-2004-5-9-115, 522861, 15345038.
146. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. 10.1016/S0092-8674(03)01018-3, 14697198.